NSB 4.00% 3.6¢ neuroscientific biopharmaceuticals ltd

Ann: NSB files new patent, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,574 Posts.
    lightbulb Created with Sketch. 302
    Quick question and sorry if it sounds dumb, but if we patent our drug to an existing , in market drug , does this speed up commercialisation of the new product , or do we have to re-test , etc as per a new product ?
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.